About Careers MedBlog Contact us

Fever Drug 'Paracetamol' Ineffective Against Osteoarthritis

by Reshma Anand on March 18, 2016 at 5:38 PM
Font : A-A+

Fever Drug 'Paracetamol' Ineffective Against Osteoarthritis

A common over-the-counter pain killer, paracetamol does not work in the treatment of osteoarthritis, a joint disorder afflicting tens of millions of elderly people, revealed a new study.

When taken on its own to alleviate pain or enhance mobility, the drug was found to be only marginally -- and insignificantly -- better than a dummy pill, according to a broad survey of 74 clinical trials covering nearly 60,000 patients.


"Our results suggest that paracetamol at any dose is not effective in managing pain in osteoarthritis," said Sven Trelle, the main architect of the meta-study and a researcher at the University of Bern in Switzerland.

Trelle and colleagues evaluated eight different non-steroid anti-inflammatory drugs, taken individually in different doses and in combination with other medications.

The drug that worked best for arthritis, they found, was diclofenac, sold in different countries under the brand names Voltaren, Aclonac and Cataflam.

The results were published in the medical journal The Lancet.

Osteoarthritis is the most common form of joint disease and the leading cause of pain among older people.

It occurs when the protective cartilage on the ends of bones wears down over time, causing acute stiffness and pain. The most common joints affected are in the hands, knees, hips and spine.

The condition gradually worsens, and no cure exists.

Among people over the age of 60, it affects about 18 percent of women and 9.5 percent of men.

"This finding is not entirely unexpected," noted Nicholas Moore and three colleagues from the department of pharmacology at the University of Bordeaux in southwestern France.

"Paracetamol has been on the market for as long as most of us remember. It efficacy has never been properly established or quantified in chronic diseases," they wrote in a comment, also published in The Lancet.

Source: AFP


Recommended Reading

Latest Drug News

 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Fever Drug 'Paracetamol' Ineffective Against Osteoarthritis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests